Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: Relation to coronary artery narrowing and plaques number

Clinica Chimica Acta

Volumn 391, Issue 1-2, 2008, Pages 74-79

  Palazzuoli, Alberto ^a   Rizzello, Vittoria ^b   Calabrò, Anna ^a   Gallotta, Maddalena ^a   Martini, Giuseppe ^a   Quatrini, Ilaria ^a   Campagna, Maria Stella ^a   Franci, Beatrice ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

Author keywords

Coronary artery disease; Natriuretic peptide; Osteoprotegerin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; OSTEOPROTEGERIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OSTEOPROTEGERIN;

ANGINA;

EID: 41949142946     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.02.008     Document Type: Article

References (25)

1. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. [Review]. N Engl J Med 339 (1998) 321-328
2. Arakawa N., Nakamura M., Aoki H., and Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27 (1996) 1656-1661
3. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
4. Sadanandan S., Cannon C.P., Chekuri K., et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
5. Lacey D.L., Timms E., Tan H.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 3597-3602
6. Dhore C.R., Cleutjens J.P., Lutgens E., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21 (2001) 1998-2003
7. Hofbauer L.C., Khosla S., Dunstan C.R., et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15 (2000) 2-12
8. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
9. Kiechl S., Schett G., Wenning G., et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109 (2004) 2175-2180
10. Jono S., Ikari Y., Shioi A., et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106 (2002) 1192-1194
11. Schoppet M., Sattler A.M., Schaefer J.R., et al. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 88 (2003) 1024-1028
12. ACC/AHA. Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) e1-e157 2007
13. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
14. Schiller N.B., Shah P.N., Crawford M., et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
15. Devereux L.B., Alonso D.R., Lutas E.M., et al. Ecocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
16. Califf R.M., Phillips H.R., Hindman M.C., et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 5 (1985) 1055-1063
17. Schoppet M., Preissner K.T., and Hofbauer L.C. RANK ligand and osteoprotegerin. Paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 22 (2002) 549-553
18. Avignon A., Sultan A., Piot C., et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care 28 (2005) 2176-2180
19. Anand D.V., Lahiri A., Lim E., et al. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type II diabetic subjects. J Am Coll Cardiol 47 (2006) 1850-1857
20. Jono S., Shioi A., Ikari Y., and e Nishizawa Y. Vascular calcification in chronic kidney disease. (Rev). J Bone Miner Metab 24 (2006) 176-181
21. Morrow D.A., de Lemos J., Sabatine M., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non ST-elevation myocardial infarction. J Am Coll Cardiol 41 (2003) 1264-1272
22. Bazzino O., Fuselli J.J., Botto F., et al. PACS group of investigators. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST elevation coronary syndromes. Eur Heart J 25 (2004) 859-866
23. Talwar S., Squire I.B., Downie P.F., Davies J.E., and Ng L.L. Plasma N-terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84 (2000) 421-424
24. Hama N., Itoh H., Nakagawa O., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
25. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies to Open Occluded Arteries (GUSTO)-IV Substudy. Circulation 108 (2003) 275-281